Literature DB >> 3496352

Defective monokine production and decreased responsiveness of polymorphonuclear leukocytes to recombinant interleukin-1 in asthmatic patients.

K H Hsieh, K H Lue.   

Abstract

Augmented IgE production and increased infections are often seen in allergic patients. As monocytes (MN) and polymorphonuclear leukocytes (PMN) are involved in both immune regulation and inflammatory reaction, MN function in terms of monokine production stimulated with lipopolysaccharide (MN supernatant; MN-sup) and its biological activity and the response of PMN to MN-sup and recombinant interleukin-1 (rIL-1) regarding chemotactic activity and expression of IgG Fc receptor (FcR) were studied in 26 normal children and 28 new and 22 hyposensitized (HS) asthmatic children. The results showed the following. There was no difference in IL-1 production, as assayed by thymocyte proliferation, among the three groups. All MN-sup from the three groups could enhance IL-2 production, but that of new patients was less efficient. In the absence of PWM, MN-sup of new patients greatly augmented the production of IgG, IgA, IgM, and IgE, but that of HS patients could enhance only IgE synthesis. MN-sup of patients enhanced less efficiently the chemotactic activity and FcR expression of PMN from healthy volunteers, and PMN from asthmatics responded much less vigorously to rIL-1 regarding the above-mentioned functions. The number of PMN with membrane IL-1 was much lower in allergic patients. Thus the abnormal MN and PMN functions may be used to explain partly the augmented IgE production and increased infections in allergic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496352     DOI: 10.1007/BF00915725

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  A study of intracutaneous skin tests and radioallergosorbent tests on 1,000 asthmatic children in Taiwan.

Authors:  K H Hsieh
Journal:  Asian Pac J Allergy Immunol       Date:  1984-06       Impact factor: 2.310

3.  Cooperation between mononuclear phagocytes and lymphocytes in immunity.

Authors:  E R Unanue
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

4.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

Authors:  L J Rosenwasser; C A Dinarello
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

5.  The effects of histamine, antihistamines, isoproterenol and theophylline on the Fc and complement receptor functions of polymorphonuclear leukocytes in asthmatic children.

Authors:  K H Hsieh
Journal:  Ann Allergy       Date:  1981-07

6.  Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

Authors:  M S Klempner; C A Dinarello; J I Gallin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 7.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

Review 8.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

9.  Effect of interleukin 1 on human thymocytes and purified human T cells.

Authors:  A L Maizel; S R Mehta; R J Ford; L B Lachman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

10.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  1 in total

1.  Comparison of abilities of recombinant interleukin-1 alpha and -beta and noninflammatory IL-1 beta fragment 163-171 to upregulate C3b receptors (CR1) on human neutrophils and to enhance their phagocytic capacity.

Authors:  J D Ogle; J G Noel; A Balasurbramaniam; R M Sramkoski; C K Ogle; J W Alexander
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.